One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The Platinum Hall of Fame
doi : 10.1016/j.eururo.2024.04.017
Volume 86, Issue 1, July 2024, Pages e1-e11
Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group 2–4 Prostate Cancer
Andrew J. Vickers a, Melissa Assel a, Matthew R. Cooperberg b, Samson W. Fine c, Scott Eggener d
doi : 10.1016/j.eururo.2024.01.005
Volume 86, Issue 1, July 2024, Pages 1-3
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study
Robert J. Motzer a, Toni K. Choueiri b, Thomas Hutson c, Sun Young Rha d, Javier Puente e, Aly-Khan A. Lalani f, Eric Winquist g, Masatoshi Eto h, Naveen S. Basappa i, Nizar M. Tannir j, Ulka Vaishampayan k, Georg A. Bjarnason l, Stéphane Oudard m, Viktor Grünwald n, Joseph Burgents o, Ran Xie p, Jodi McKenzie p, Thomas Powles q
doi : 10.1016/j.eururo.2024.03.015
Volume 86, Issue 1, July 2024, Pages 4-9
Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis
Soumyajit Roy a †, Gagan Fervaha b †, Daniel E. Spratt c †, Yilun Sun d †, Amar U. Kishan e, Andrew Loblaw f, Shawn Malone g, Michael Ong h, Fred Saad i ‡, Christopher J.D. Wallis c j ‡, Scott C. Morgan g ‡
doi : 10.1016/j.eururo.2024.03.018
Volume 86, Issue 1, July 2024, Pages 10-17
Metastatic Hormone-sensitive Prostate Cancer: Patient Selection for Prostate Radiotherapy
Deep Chakrabarti a, Chris C. Parker a b
doi : 10.1016/j.eururo.2024.04.011
Volume 86, Issue 1, July 2024, Pages 18-19
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium
Johan Bjerner a, Ola Bratt b c, Kirsti Aas d, Peter C. Albertsen e, Sophie D. Fosså f g, Rune KvÃ¥le h i, Hans Lilja j k, Christoph Müller l, Stig Müller m, Andreas Stensvold n, Owen Thomas o, Oluf D. Røe p q, Andrew Vickers r s, Jochen Walz t, Sigrid V. Carlsson r s u †, Jan Oldenburg g v â€
doi : 10.1016/j.eururo.2023.04.028
Volume 86, Issue 1, July 2024, Pages 20-26
European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines
Jennifer Kranz a b, Riccardo Bartoletti c, Franck Bruyère d e, Tommaso Cai f, Suzanne Geerlings g h, Bela Köves i, Sören Schubert j, Adrian Pilatz k, Rajan Veeratterapillay l, Florian M E Wagenlehner k, Kathrin Bausch m, Wout Devlies n, József Horváth o, Lorenz Leitner p, Guglielmo Mantica q, Tunde Mezei r, Emma J. Smith s, Gernot Bonkat t
doi : 10.1016/j.eururo.2024.03.035
Volume 86, Issue 1, July 2024, Pages 27-41
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer
Nicolaus F. Debatin a, Elena Bady a, Tim Mandelkow a, Zhihao Huang a, Magalie C.J. Lurati a, Jonas B. Raedler a b, Jan H. Müller a, Eik Vettorazzi c, Henning Plage d, Henrik Samtleben f, Tobias Klatte d i, Sebastian Hofbauer d, Sefer Elezkurtaj e, Kira Furlano d, Sarah Weinberger d, Paul Giacomo Bruch d, David Horst e, Florian Roßner e, Simon Schallenberg e, Andreas H. Marx f…Niclas C. Blessin a â€
doi : 10.1016/j.eururo.2024.01.023
Volume 86, Issue 1, July 2024, Pages 42-51
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)
Wesley R. Armstrong a b, Amar U. Kishan c d, Kiara M. Booker a, Tristan R. Grogan e, David Elashoff e, Ethan C. Lam a, Kevyn J. Clark a, Michael L. Steinberg c d, Wolfgang P. Fendler a f, Thomas A. Hope g, Nicholas G. Nickols c d h, Johannes Czernin a d, Jeremie Calais a d
doi : 10.1016/j.eururo.2024.01.012
Volume 86, Issue 1, July 2024, Pages 52-60
Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial
Jim C. Hu a, Melissa Assel b, Mohamad E. Allaf c, Behfar Ehdaie d, Andrew J. Vickers b, Andrew J. Cohen c, Benjamin T. Ristau e, David A. Green f, Misop Han c, Michael E. Rezaee c, Christian P. Pavlovich c, Jeffrey S. Montgomery g, Keith J. Kowalczyk h, Ashley E. Ross i, Shilajit D. Kundu i, Hiten D. Patel i, Gerald J. Wang f, John N. Graham j, Jonathan E. Shoag k, Ahmed Ghazi c…Edward M. Schaeffer i
doi : 10.1016/j.eururo.2023.12.015
Volume 86, Issue 1, July 2024, Pages 61-68
Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer
Yuzhen Zhou a, Vincent D. D'Andrea b c, Surish P. Shanmugam a c, Isabella Stelter a, Dag R. Stormoen a d, Rea Chroneos a, Timothy Hanlon a, Ilana Epstein e, Raie T. Bekele a c, William J. Anderson c f, Filipe F.L. Carvalho b c g, Joaquim Bellmunt c e, Kent W. Mouw a c g h
doi : 10.1016/j.eururo.2024.03.013
Volume 86, Issue 1, July 2024, Pages 69-71
Retroperitoneal Robotic Partial Nephrectomy with the Hugo RAS System
Josep M. Gaya †, Alessandro Uleri †, Andrea Gallioli, Giuseppe Basile, Angelo Territo, Alba Farré, Edgar Suquilanda, Paolo Verri, Joan Palou, Alberto Breda
doi : 10.1016/j.eururo.2023.06.001
Volume 86, Issue 1, July 2024, Pages 71-73
Re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61–68
Ilias Giannakodimos a b *
doi : 10.1016/j.eururo.2024.02.032
Volume 86, Issue 1, July 2024, Page e12
Reply to Ilias Giannakodimos’ Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61–68
Jim C. Hu a, Edward M. Schaeffer b, Andrew J. Vickers c
doi : 10.1016/j.eururo.2024.04.014
Volume 86, Issue 1, July 2024, Page e13
Re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61–68
Geoffrey H. Rosen a b, Nicholas H. Chakiryan a b, Katie S. Murray c d
doi : 10.1016/j.eururo.2024.03.043
Volume 86, Issue 1, July 2024, Page e14
Reply to Geoffrey H. Rosen, Nicholas H. Chakiryan, and Katie S. Murray’s Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61–68
Jim C. Hu a, Andrew J. Vickers b, Edward M. Schaeffer c
doi : 10.1016/j.eururo.2024.04.013
Volume 86, Issue 1, July 2024, Page e15
Beyond Statistical Significance: Unveiling the Advantages of Transperineal Versus Transrectal Prostate Biopsies
Peter Ka-Fung Chiu a, Xiaobo Wu a, Giorgio Gandaglia b c, European Association of Urology Young Academic Urologists Prostate Cancer Working Party
doi : 10.1016/j.eururo.2024.03.041
Volume 86, Issue 1, July 2024, Pages e16-e17
Reply to Peter Ka-Fung Chiu, Xiaobo Wu, Giorgio Gandaglia, European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Beyond Statistical Significance: Unveiling the Advantages of Transperineal Versus Transrectal Prostate Biopsies. Eur Urol. In press
Jim C. Hu a, Andrew J. Vickers b, Edward M. Schaeffer c
doi : 10.1016/j.eururo.2024.04.012
Volume 86, Issue 1, July 2024, Page e18
Re: Renu S. Eapen, James P. Buteau, Price Jackson, et al. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. 2024;85:217–226
Elif Hindié a b, Christophe Champion c, Clément Morgat a
doi : 10.1016/j.eururo.2024.02.030
Volume 86, Issue 1, July 2024, Pages e19-e20
Re: Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial. Eur Urol 2024;85:105–11
José D. Cardona Ortegón a b, Laura A. Campaña Perilla a c, Laura M. Olarte Bermúdez d
doi : 10.1016/j.eururo.2024.03.042
Volume 86, Issue 1, July 2024, Page e21
Re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol 2024;85:146–53
José David Cardona Ortegón a b, Samuel Serrano b c, Daniel Romero Cortes b c
doi : 10.1016/j.eururo.2024.02.033
Volume 86, Issue 1, July 2024, Page e22
Re: Erdafitinib in BCG-treated High-risk Non–muscle-invasive Bladder Cancer
Igor Duquesne, Alexandre de la Taille
doi : 10.1016/j.eururo.2024.02.021
Volume 86, Issue 1, July 2024, Pages 74-75
Re: Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localised Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-year Experience
Olivier Windisch a b, Massimo Valerio a b
doi : 10.1016/j.eururo.2024.03.005
Volume 86, Issue 1, July 2024, Page 75
Re: Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer
Alice Bourillon, Karim Bensalah
doi : 10.1016/j.eururo.2024.03.010
Volume 86, Issue 1, July 2024, Page 76
Re: Multi-omic Profiling of Clear Cell Renal Cell Carcinoma Identifies Metabolic Reprogramming Associated with Disease Progression
Aimin Jiang a †, Le Qu b †, Chen Cai c †, Peng Luo d †, Linhui Wang a
doi : 10.1016/j.eururo.2024.04.001
Volume 86, Issue 1, July 2024, Pages 76-77
Re: Autologous Platelet Rich Plasma (A-PRP) Combined with Pelvic Floor Muscle Training for the Treatment of Female Stress Urinary Incontinence (SUI): A Randomized Control Clinical Trial
Andrea Braga a b, Andrea Papadia b c, Maurizio Serati d
doi : 10.1016/j.eururo.2024.03.009
Volume 86, Issue 1, July 2024, Pages 77-78
Re: Laparoscopic Sacrocolpopexy Versus Vaginal Sacrospinous Fixation for Vaginal Vault Prolapse: A Randomised Controlled Trial and Prospective Cohort (SALTO-2 Trial)
Andrea Braga a b, Andrea Papadia b c, Maurizio Serati d
doi : 10.1016/j.eururo.2024.03.008
Volume 86, Issue 1, July 2024, Pages 78-79
